Thousands of patients were implanted with the recalled Stryker hip components, and now find themselves at risk of premature device failure and other severe complications. We are certainly expecting that many more cases will be filed.
New York, New York (PRWEB) February 21, 2013
A Stryker hip lawsuit plaintiff has moved to have all federal claims stemming from last year’s Rejuvenate and ABG II Modular-Neck Hip Stem recall transferred to U.S. District Court, District of Minnesota for pretrial proceedings, Bernstein Liebhard LLP reports. According to a Motion filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) on February 19th, at least 30 Stryker Rejuvenate lawsuits have been filed in 12 federal districts since Stryker announced the Rejuvenate recall in July 2012. The Motion states that some 53,000 Rejuvenate and ABG II modular-neck stem units were produced by Stryker after the components were brought to market in 2008, and asserts that many more plaintiffs will file similar claims in the future. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML))*
“Thousands of patients were implanted with the recalled Stryker hip components, and now find themselves at risk of premature device failure and other severe complications. We are certainly expecting that many more cases will be filed,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Stryker hip lawsuit evaluations to individuals who suffered metallosis, hip implant failure and other complications, related to the Stryker Rejuvenate recall.
According to court records, a consolidated litigation has already been established in Bergen County Superior court for all Stryker hip lawsuits filed in the state of New Jersey. Judge Brian R. Martinotti, who is overseeing the New Jersey state litigation, held an initial conference on February 20th. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
Stryker Hip Recall
The Stryker Rejuvenate hip recall was announced after data indicated the components were at risk for fretting and corrosion at the modular neck junction. According to Stryker, patients implanted with the recalled components may experience pain, swelling and adverse local tissue reactions. In its most recent recall update, Stryker advised patients affected by the Stryker Rejuvenate recall to undergo metal ion testing and cross sectional imaging, even if they are not experiencing any problems with their hip. According to the company, there have been reports of patients without symptoms who experienced high levels of metal ions in their blood and/or adverse local tissue reactions.*
According to Bernstein Liebhard LLP, patients affected by the Stryker hip recall may have already received a letter from their doctor with details about the recently-established Stryker Broadspire claims process. In its most recent recall update, Stryker said it had retained Broadspire Services, Inc., a third-party claims administrator, to work directly with patients to manage medical claims and address out-of-pocket costs relating to the Stryker Rejuvenate recall.** Bernstein Liebhard LLP is advising patients that they should consider speaking with an attorney before they begin a Broadspire Stryker claim, as any information they disclose in the course of the claims process could be used as evidence in their Stryker hip lawsuit.**
Individuals who have suffered hip implant failures, metal poisoning, pain, or revision surgery allegedly due to the recalled Rejuvenate and ABG II components may be entitled to file a Stryker hip lawsuit seeking compensation for their medical care, pain and suffering, and other damages. A wealth of information regarding the Stryker Rejuvenate recall is available at Bernstein Liebhard LLP’s website. Free lawsuit evaluations can be obtained by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP